Investor Presentation Q2FY23 slide image

Investor Presentation Q2FY23

Among top 20 Corporates in IPM in Prescriptions at Core Specialties in H1 (Apr-Sep YTD) % Growth Specialities FDC IPM % MS Rank Overall 51 47 5.6 13 GP-NON.MBBS 47 41 9.7 4 GP - MBBS 65 38 7.2 9 PEDIATRICIAN 76 72 5.7 16 ENT SPECIALIST 57 51 5.1 16 OPHTHALMOLOGIST 14 37 5.6 10 (Source: IQVIA-Medical Audit data Sep 2022 H1 (Apr-Sep) 1e) FDC
View entire presentation